Navigating the Dynamic Indian Clinical Trial Landscape
Friday, June 28, 2013 | ARCHIVE NOW AVAILABLE
India’s vast and growing population means the clinical trial business can potentially be worth up to a billion dollars per year by 2016! With this opportunity, the Indian government is taking serious action to better regulate and oversee the clinical trials the process.
This presentation will examine:
- Recent changes in Indian clinical trial regulations
- Immediate and long term impacts
- Foreseeable opportunities
A live Q&A with the audience will follow the main presentation.
Dr. Josemund Menezes, MBBS
Regional Director, Clinical Development (Asia-Pacific), Sanofi Pasteur
Dr. Josemund Menezes is the Regional Director, Clinical Development (Asia-Pacific) at Sanofi Pasteur, the vaccines division of Sanofi. He is based at the India Affiliate Head Office in Mumbai & part of the Asia-pacific regional Clinical development team working on New Vaccines & therapeutics.
Dr. Menezes is a medical doctor and holds an MBBS degree from the MUHS University, followed by advanced certifications in Project Management, Clinical Research and Vaccinology. Josemund has been spearheading the planning and clinical development activities for Sanofi Pasteur’s novel Dengue vaccine candidate in India, since 2010. Besides Dengue, he has supported clinical development programs in the region for Rabies, Pneumonia, Cholera and Japanese Encephalitis.
His previous assignment at Sanofi as Medical Advisor & Clinical Project Leader, included project management for both Sanofi India projects (Cardiology, Oncology, Thrombosis therapeutic areas) as well as CRO outsourced projects in India. Prior to his role at SANOFI, he served as Medical Monitor for India’s first ever Phase I HIV Vaccine trial conducted at NARI, Pune in 2005 (an ICMR center).
Dr. Menezes has supported and successfully managed over 20 clinical studies & has served as Guest faculty at the University of Pune and University of Goa for Clinical Research & Project Management.